We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| AngioDynamics Inc | NASDAQ:ANGO | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.01 | -0.17% | 5.78 | 5.63 | 6.02 | 5.975 | 5.71 | 5.83 | 357,073 | 00:55:10 |
From May 2019 to May 2024
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will present at the following two investor conferences in March:
Conference: Barclays Global Healthcare Conference Location: Miami Beach, FL Date: Wednesday, March 11, 2020 Presentation: 4:50 p.m. ET Speakers: Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President & Chief Financial Officer
Conference: Oppenheimer Healthcare Conference Location: New York, NY Date: Wednesday, March 18, 2020 Presentation: 10:20 a.m. ET Speaker: Stephen Trowbridge, Executive Vice President & Chief Financial Officer
A live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following each event.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products, and venous products. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200227005878/en/
Investors: AngioDynamics, Inc. Stephen Trowbridge, Executive Vice President & CFO (518) 795-1408
1 Year AngioDynamics Chart |
1 Month AngioDynamics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
